Yusuf Hamied, the Litvak founder of India’s generic pharmaceuticals giant Cipla, reports on his company’s efforts to develop drug treatments for the novel Wuhan virus.

Hindu Business Line-Cipla doyen sees opportunity to tackle Covid-19 like they did HIV -

All articles as on Mar 23 1

All articles as on Mar 23 3

All articles as on Mar 23 4